Page1234...27
2023 Meeting on Hematologic Malignancies - How I Test and Manage CHIP/CCUS
2023 Meeting on Hematologic Malignancies - How I Treat Patients with MDS: Clinical Trials
2023 Meeting on Hematologic Malignancies - How I Treat Ph Negative B-ALL in Older Patients
2023 Meeting on Hematologic Malignancies - How I Treat Ph+ ALL
2023 Meeting on Hematologic Malignancies - Is There Still a Role for Auto SCT in Mantle Cell Lymphoma in 2023?
2023 Meeting on Hematologic Malignancies - Is There Still a Role for Transplant in MM?
2023 Meeting on Hematologic Malignancies - Optimizing Treatment for Frailty in MM
2023 Meeting on Hematologic Malignancies - Panel Discussion with Drs. Advani and Aldoss
2023 Meeting on Hematologic Malignancies - Panel Discussion with Drs. Burger and Allan
2023 Meeting on Hematologic Malignancies - Panel Discussion with Drs. Kumar and Rosko
2023 Meeting on Hematologic Malignancies - Panel Discussion with Drs. Raje and Richard
2023 Meeting on Hematologic Malignancies - Panel Discussion with Drs. Singh and Sekeres
2023 Meeting on Hematologic Malignancies - Panel Discussion with Drs. Stein and Hexner
2023 Meeting on Hematologic Malignancies - Panel Discussion with Drs. Williams, Wagner-Johnston and Phillips
2023 Meeting on Hematologic Malignancies - PET-Adapted Treatment of Early-Stage Hodgkin Lymphoma: Preserving Cures, Reducing Risk
2023 Meeting on Hematologic Malignancies - Q & A with Dr. Kebriaei
2023 Meeting on Hematologic Malignancies - Should Time-Limited Front-Line Therapy Be the New Standard in CLL?
2023 Meeting on Hematologic Malignancies - Special Education Session: How I Treat a Newly Diagnosed Older Patient
2023 Meeting on Hematologic Malignancies - Where Do I Use Immunotherapy in Myeloma?
2023 Meeting on Hematologic Malignancies - Which BTK Inhibitor in Front-Line and Relapsed CLL Treatment?
2023 Highlights of ASH North America Complete Meeting Webcast
2023 Highlights of ASH in North America Acquired Bone Marrow Failure Syndromes
2023 Highlights of ASH in North America Acute Lymphoblastic Leukemia
2023 Highlights of ASH in North America Acute Myeloid Leukemia
2023 Highlights of ASH in North America Chronic Lymphocytic Leukemia
2023 Highlights of ASH in North America Disorders of Hemostasis
2023 Highlights of ASH in North America Hematopoietic Stem Cell Transplantation
2023 Highlights of ASH in North America ITP/TTP, Immune Hemolysis, and aHUS
2023 Highlights of ASH in North America Lymphoma
2023 Highlights of ASH in North America Myelodysplastic Syndromes
Page1234...27